Allergies and COPD Flare-Up Risk Study
Part of Lungs & breathing clinical trials.
This study looks at how allergies (called atopy) might affect how often people with COPD have flare-ups (exacerbations). It helps doctors understand if allergies play a role in COPD symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 70 years old.
- You have been diagnosed with COPD (chronic obstructive pulmonary disease).
- You do not have any known allergies, such as hay fever or eczema.
- You do not have other chronic lung diseases (like asthma or bronchiectasis).
- You have not had a respiratory infection or taken oral steroids in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at factors that can predict when chronic obstructive pulmonary disease (COPD) will flare up. It may help doctors identify people at higher risk sooner and tailor care to prevent flare-ups.
This study uses a simple blood test to help doctors decide if people having a COPD flare-up need antibiotics or steroids. It may help you get the right treatment faster and avoid unnecessary medications.
This study looks at how the body’s “innate” (first-line) immune system works in people with COPD compared with healthy volunteers. It may help researchers understand COPD inflammation and how immune responses could be targeted in the future.
This study looks at people with COPD who have a sudden worsening of symptoms, called an exacerbation. It tracks what symptoms they have and how they do over time to help doctors understand better how to treat these episodes.
This study follows people with COPD flare-ups (sudden worsening of breathing) to better understand what happens and what might help. You may be asked for consent and lung-function tests if you meet the breathing and age requirements.
This study looks at people hospitalized for a COPD flare-up (“exacerbation”). It may help improve how flare-ups are treated because participants need to receive the usual rescue medicines like steroids and/or antibiotics and then follow a study plan.
Hear when a new Chronic Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.